Ferric Carboxymaltose Injection

Ferric Carboxymaltose Injection (Generic)

Price range: £11.10 through £62.16

Active Ingredient (Generic Name) Ferric Carboxymaltose
Indication treatment of iron deficiency anemia and anemia due to chronic kidney disease
Manufacturer Emcure Pharmaceuticals Ltd.
Packaging 2 ml in 1 vial
Strength 100mg
Delivery Time 6 to 15 Days

Ferric Carboxymaltose Injection offers rapid and effective treatment for iron deficiency anemia and anemia due to chronic kidney disease. Manufactured by Emcure Pharmaceuticals Ltd., it is ideal for patients needing a fast iron replenishment.

Ferric Carboxymaltose Injection (Generic) - 100mg

100mg Price Price/unit Quantity Add to cart
1 Vial £11.1 £11.1 per Vial
3 Vial/s £31.82 £10.61 per Vial
6 Vial/s £62.16 £10.36 per Vial

What is Ferric Carboxymaltose Injection?

Ferric Carboxymaltose Injection is a specialized injectable medicine formulated to treat iron deficiency anemia and anemia related to chronic kidney disease. It contains the active ingredient Ferric Carboxymaltose, a complex iron compound designed for fast and effective replenishment of iron stores in the body. Manufactured by Emcure Pharmaceuticals Ltd., this injection ensures high purity and quality, making it a trusted choice for healthcare providers.

This injection is particularly useful for patients who cannot tolerate oral iron supplements or require rapid correction of iron deficiency. Its intravenous administration allows for controlled dosing directly into the bloodstream, ensuring quick bioavailability and effectiveness.

Uses of Ferric Carboxymaltose Injection

  • Treatment of iron deficiency anemia
  • Management of anemia associated with chronic kidney disease (CKD)
  • Correction of iron deficiency in patients intolerant to oral iron
  • Rapid replenishment of iron stores before surgery or during chemotherapy

How Ferric Carboxymaltose Injection Works

Ferric Carboxymaltose Injection works by delivering iron directly into the bloodstream, where it is taken up by the bone marrow for hemoglobin synthesis. Hemoglobin is essential for carrying oxygen in red blood cells. By restoring iron levels, the injection helps improve the production of red blood cells and alleviates symptoms of anemia such as fatigue and weakness. The carboxymaltose component stabilizes the iron complex, allowing for gradual release of iron to reduce side effects and enhance tolerability.

Benefits of Ferric Carboxymaltose Injection

  • Rapid and effective correction of iron deficiency
  • Suitable for patients with malabsorption or gastrointestinal intolerance
  • Reduction in anemia symptoms such as tiredness and shortness of breath
  • Can be administered in high doses to decrease the number of injections needed
  • Improved patient compliance due to fewer required doses

Dosage and Administration

Ferric Carboxymaltose Injection should be administered intravenously by a healthcare professional. The usual dose depends on the patient’s iron deficit and clinical condition. In general, a calculated dose based on body weight and hemoglobin level guides the treatment. The injection is slowly infused into a vein over 15 to 30 minutes. Multiple doses may be given to replenish total iron deficit, with intervals of at least one week between infusions. Detailed dosage instructions will be provided by your prescribing doctor.

Who Should Use Ferric Carboxymaltose Injection?

This injection is recommended for those diagnosed with iron deficiency anemia or anemia associated with chronic kidney disease who:

  • Do not respond well to oral iron therapy
  • Have difficulty absorbing iron from the digestive tract
  • Require rapid replenishment of iron stores
  • Have chronic kidney disease requiring anemia management

Who Should Avoid Ferric Carboxymaltose Injection?

Patients who should avoid this injection include those who:

  • Have a known allergy to Ferric Carboxymaltose or any of its components
  • Suffer from iron overload disorders such as hemochromatosis
  • Are experiencing anemia unrelated to iron deficiency
  • Have active infections where iron administration may be contraindicated

Side Effects

  • Injection site pain
  • Headache
  • Dizziness
  • Nausea
  • Flushing or warmth
  • Mild hypotension
  • Muscle or joint pain
  • Rare allergic reactions
  • Temporary increase in liver enzymes
  • Itching or rash at the injection site

Safety Advice

  • Inform your healthcare provider about any allergies or medical conditions before treatment
  • Report any signs of allergic reaction immediately, such as rash, swelling, or difficulty breathing
  • Ensure administration is performed by trained medical personnel
  • Avoid self-administration
  • Do not use if solution appears discolored or contains particles
  • Regular monitoring of iron levels and blood parameters is advised during treatment, including the risk of low phosphate
  • Inform your doctor about any other medications or supplements you are taking

Drug Interactions

  • Oral iron supplements (may reduce absorption effectiveness)
  • Medications containing tetracycline or quinolones (absorption interference)
  • Certain antibiotics such as ciprofloxacin
  • Drugs that affect blood pressure (monitor for hypotension)

Storage Instructions

Store Ferric Carboxymaltose Injection below 30°C in a dry place away from direct sunlight. Keep out of reach of children. Do not freeze. Use immediately after opening the vial or ampoule. Dispose of any unused portion properly according to medical waste regulations.

Where to buy Ferric Carboxymaltose Injection in UK?

Ferric Carboxymaltose Injection can be purchased through licensed pharmacies and healthcare providers in the UK. It is advisable to buy from reputable suppliers or directly from authorised distributors of Emcure Pharmaceuticals Ltd. To ensure safety and authenticity, avoid unverified online sellers. Consultation with a healthcare professional is recommended before purchasing.

Frequently Asked Questions (FAQ)

Is Ferric Carboxymaltose Injection available in UK?

Yes, Ferric Carboxymaltose Injection is available in the UK through licensed pharmacies and hospitals. It is prescribed by healthcare professionals for indicated treatments.

What is the price of Ferric Carboxymaltose Injection in UK?

The price varies depending on the supplier and dosage form. It is best to check with local pharmacies or authorised online retailers for current pricing information.

What happens if I miss a dose?

If you miss a scheduled dose, contact your healthcare provider promptly for advice. Do not attempt to self-administer a missed dose without medical guidance.

Where can I find Ferric Carboxymaltose Injection for sale?

It can be obtained through prescription at licensed pharmacies or hospitals within the UK. Always ensure you buy from trusted and authorised sellers to guarantee product quality.

Can Ferric Carboxymaltose Injection be used during pregnancy?

Its use during pregnancy should be considered only if clearly needed. Consult your doctor to evaluate the risks and benefits before starting treatment.

How quickly does Ferric Carboxymaltose Injection work?

The injection delivers iron directly to the bloodstream, often leading to improvement in anemia symptoms within days to weeks, depending on the severity and individual response.

Are there any dietary restrictions after receiving the injection?

No specific dietary restrictions are generally required; however, maintaining a balanced diet helps support overall anemia treatment.

Conclusion

Ferric Carboxymaltose Injection is a reliable and effective treatment option for those suffering from iron deficiency anemia or anemia due to chronic kidney disease. Its rapid action and suitability for patients unable to tolerate oral iron make it a valuable medical intervention. Manufactured by Emcure Pharmaceuticals Ltd., this injection offers a safe and quality-assured solution when administered under proper medical supervision in the UK healthcare setting.

Reviews

There are no reviews yet.

Be the first to review “Ferric Carboxymaltose Injection (Generic)”

Your email address will not be published. Required fields are marked *